Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jermo J. van Toor"'
Autor:
Brenda L. Den Oudsten, Jermo J. van Toor, Joachim G.J.V. Aerts, Kiki Cheung, Bruno H. Stricker, Sabine Visser, Nico C. van Walree, Mark de Mol
Publikováno v:
Clinical Lung Cancer, 19(4), E503-E516. Elsevier
Clinical Lung Cancer, 19(4), e503-e516. Elsevier
Clinical Lung Cancer, 19(4), e503-e516. Elsevier
Introduction.In patients with advanced non–small-cell lung cancer, the treatment benefits and risks need to be constantly weighed. We explored patient-reported satisfaction with therapy (SWT) and assessed its value in addition to quality of life (Q
Autor:
Gert-Jan Braunstahl, J. C. C. M. in ’t Veen, Jermo J. van Toor, Jasper H Kappen, Sophie C van der Mark
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 58(5)
Introduction: Severe eosinophilic asthma is an incapacitating disease. Mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, proved to be effective as an add-on therapy in patients with ...
Autor:
Nico van Walree, Jeannine Huisbrink, Anton J.M. van Boxem, Sabine Visser, Bruno H. Stricker, Nils E. van ‘t Veer, Jermo J. van Toor, Joachim G.J.V. Aerts
Publikováno v:
European Respiratory Journal, 52(4):1800884. European Respiratory Society
Optimal survival benefit from different lines of anticancer treatment in advanced nonsmall cell lung cancer (NSCLC) requires conservation of renal function. We evaluated the development of renal impairment during pemetrexed maintenance.In a prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcf7a56ff2b3b7d596138f93ed7ddb9
https://pure.eur.nl/en/publications/84295b6a-385a-4a25-b9c7-62bc1d293e2d
https://pure.eur.nl/en/publications/84295b6a-385a-4a25-b9c7-62bc1d293e2d
Autor:
Jeannine Huisbrink, Bruno H. Stricker, Nico van Walree, Joachim G.J.V. Aerts, Sabine Visser, Jermo J. van Toor
Publikováno v:
Journal of Thoracic Oncology. 12:S894-S895
Autor:
Sabine Visser, Brenda L. Den Oudsten, Joachim G.J.V. Aerts, Bruno H. Stricker, Mark de Mol, Nico van Walree, Jermo J. van Toor
Publikováno v:
Journal of Thoracic Oncology. 12:S673-S674